8-KEarnings & ResultsExhibits & Filings

THERMO FISHER SCIENTIFIC INC. 8-K Report, Financial Results (Jul 6, 2020)

Filed July 6, 2020For Securities:TMO

Summary

Thermo Fisher Scientific Inc. (TMO) filed an 8-K on July 6, 2020, to announce preliminary results for the fiscal quarter ended June 27, 2020. While the 8-K itself is a brief filing, it incorporates a press release that provides key financial and operational updates. Investors should note that this filing is primarily for furnishing information rather than making new declarations, as indicated by the disclaimer that the information is not deemed "filed" for purposes of Section 18 of the Exchange Act. The core of this announcement revolves around the company's performance during a period significantly impacted by the COVID-19 pandemic. The press release (Exhibit 99.1) likely details revenue figures, earnings, and potentially segment performance, especially highlighting areas that may have seen increased demand due to the pandemic, such as diagnostics and life sciences research. Investors should focus on any commentary regarding the pandemic's impact on demand, supply chain, and the company's outlook, as well as any strategic updates.

Key Highlights

  • 1Thermo Fisher Scientific announced preliminary results for its fiscal quarter ended June 27, 2020, via an 8-K filing on July 6, 2020.
  • 2The filing incorporates a press release (Exhibit 99.1) containing the detailed financial and operational update.
  • 3Information furnished in this 8-K is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
  • 4The report includes a cautionary statement regarding forward-looking statements, emphasizing risks and uncertainties, particularly those related to the COVID-19 pandemic.
  • 5Key factors that could affect actual results are listed, including the pandemic's duration and severity, technological changes, economic conditions, and potential impacts from acquisitions.
  • 6The company references its Form 10-Q for the quarter ended March 28, 2020, for a more detailed discussion of risk factors.

Frequently Asked Questions

The main purpose of this 8-K filing is to furnish investors with preliminary financial and operational results for Thermo Fisher Scientific's fiscal quarter ended June 27, 2020, as announced in a press release.

The filing highlights significant risks and uncertainties, including the duration and severity of the COVID-19 pandemic, the need for product innovation, economic conditions, international operations, intellectual property protection, government regulations, and potential issues with pending acquisitions, such as the QIAGEN N.V. acquisition.

More detailed information regarding the risks and uncertainties that could affect Thermo Fisher Scientific's actual results can be found in the Company's Quarterly Report on Form 10-Q for the quarter ended March 28, 2020, under the 'Risk Factors' section.

No, the information contained in Item 2.02 of this Form 8-K and its incorporated press release is furnished, not "filed." This means it is not subject to the liabilities of Section 18 of the Securities Exchange Act of 1934, unless specifically incorporated by reference into a registration statement or other filing.